COPD: Pathogenesis and Clinical Features
Pneumonia II: Pathophysiology
T Cell Types and Functions
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 23, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Silvia Galván-Peña1, Juliette Leon1,2, Kaitavjeet Chowdhary1
1Department of Immunology, Harvard Medical School, Boston, MA 02115.
Severe COVID-19 involves immune dysfunction. Researchers found that T regulatory cells (Tregs) with increased FoxP3 expression worsen outcomes by suppressing antiviral responses and promoting inflammation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: